Albert’s AI-enabled platform transforms materials science R&D and accelerates chemical innovation OAKLAND, Calif. -- Albert Invent, whose end-to-end R&D platform accelerates chemical innovation in materials science through the application of AI and machine learning, today announced a growth funding round led by J.P. Morgan Private Capital’s Growth Equity Partners, with participation from Coatue and TCV. This [...]

Cambridge, UK – Cresset, a leading provider of integrated in silico solutions for small molecule drug discovery announces the release of its Flare platform V10, bringing enhanced scientific features for both computational and medicinal chemists. The latest release includes significantly enhanced Free Energy Perturbation (FEP) calculations with the inclusion of Absolute FEP, Protein-protein docking, and Protein-Ligand [...]

The QuantumScale platform enables costs of less than 1 cent per cell with workflows across an unprecedented scale SAN DIEGO -- Scale Biosciences (Scale Bio™), a leader in innovative and scalable single cell analysis solutions, today announced the availability of its QuantumScale Single Cell RNA kits, a set of next-generation single cell products which can capture and [...]

Together, these appointments offer a new dimension to IonOpticks’ business development approach. Melbourne: IonOpticks, a world-leading provider of chromatography solutions, today announce two key appointments to strengthen its global operations, enhancing access and support for the LC-MS industry. Erik Verschuuren joins as Head of Global Sales, while Zac Anderson takes the role of Business Development Manager [...]

Commercial launch of UG 100 Solaris which includes new chemistry, software, and simplified workflows for the UG 100 sequencing platform, now with expanded applications support and integration with leading 'omics' technologies Over 50% increase in output to 10 to 12 billion reads per wafer and pricing reduced by 20% to $0.24 per million reads, enabling the $80 genome Increased sensitivity [...]

Company expands multiomics portfolio with new roadmap technologies spanning genomics, spatial, single cell, CRISPR, and methylation, as well as a new multimodal data analysis platform Built on Illumina's powerful sequencers, new, disruptive omics solutions surpass industry standards forquality, scale, accuracy, and replicability SAN DIEGO -- Illumina, Inc. (NASDAQ: ILMN) has unveiled a series of roadmap innovations, [...]

SAN DIEGO -- Singular Genomics Systems, Inc., an innovator in high-throughput spatial multiomics technologies designed to advance precision medicine, today announced key development milestones for its G4X™ Spatial Sequencer at the Advances in Genome Biology and Technology (AGBT) conference in Marco Island, Florida. G4X Early Access Program Ongoing and Broader Availability on Track The G4X [...]

A. Preview of timsTOF Ultra 2 system with novel Athena Ion Processor (AIP): - Improves protein group identification in single-cell proteomics (SCP) by 15%-20%, and peptide identifications in SCP by 20%-25% -Advances immunopeptidomics with 15%-20% more immunopeptide identifications B. Launch of DeutEx™ software for hydrogen-deuterium exchange (HDX-MS) analysis C. OmniScape™ 2025b: a breakthrough in top-down protein sequencing software D. Advances in [...]

Appointment to drive commercial growth of eProtein Discovery and support strategic expansion Cambridge, UK: Nuclera, the biotechnology company accelerating protein expression and optimization through its benchtop eProtein Discovery™ system, today announced that it has appointed Seth Benson as Chief Financial Officer. Seth joins CEO, Dr Michael Chen, on the executive team to advance commercial and strategic [...]

Officinae Bio's AI-driven sequence optimization expands Maravai's family of brands, enabling rapid, cost-effective nucleic acid therapy development SAN DIEGO -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, announced today that it has completed its previously announced acquisition of Officinae Bio’s DNA and RNA business. This [...]